Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)

NCT05082142 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT05082142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05082142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)
Lead sponsor
Northwestern University
Phase
Phase 4
Overall status
Completed
Start date
September 17, 2021
Completion date
December 14, 2022
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hypertrophy, kidney calculi, urologic diseases